P53 and prognosis: New insights and further complexity

被引:245
作者
Vousden, KH
Prives, C
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[2] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
关键词
D O I
10.1016/j.cell.2004.12.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the massive amount of knowledge that has accumulated about p53, there is still much to learn about its role in tumor suppression. New papers now provide evidence that levels of Mdm2 in humans or presence of mutant forms of p53 in mice can have profound impacts on survival and tumorigenesis. These findings may lead to new diagnostic and therapeutic approaches to treating cancer patients.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 19 条
  • [1] A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
    Bond, GL
    Hu, WW
    Bond, EE
    Robins, H
    Lutzker, SG
    Arva, NC
    Bargonetti, J
    Bartel, F
    Taubert, H
    Wuerl, P
    Onel, K
    Yip, L
    Hwang, SJ
    Strong, LC
    Lozano, G
    Levine, AJ
    [J]. CELL, 2004, 119 (05) : 591 - 602
  • [2] Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
    Bykov, VJN
    Issaeva, N
    Shilov, A
    Hultcrantz, M
    Pugacheva, E
    Chumakov, P
    Bergman, J
    Wiman, KG
    Selivanova, G
    [J]. NATURE MEDICINE, 2002, 8 (03) : 282 - 288
  • [3] The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
    Cadwell, C
    Zambetti, GP
    [J]. GENE, 2001, 277 (1-2) : 15 - 30
  • [4] The p53 Paddy Wagon - COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest
    Corcoran, CA
    Huang, Y
    Sheikh, MS
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (08) : 721 - 725
  • [5] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
    Dumont, P
    Leu, JIJ
    Della Pietra, AC
    George, DL
    Murphy, M
    [J]. NATURE GENETICS, 2003, 33 (03) : 357 - 365
  • [6] Ganguli G, 2003, MOL CANCER RES, V1, P1027
  • [7] Iwakuma T, 2003, MOL CANCER RES, V1, P993
  • [8] Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
    Lang, GA
    Iwakuma, T
    Suh, YA
    Liu, G
    Rao, VA
    Parant, JM
    Valentin-Vega, YA
    Terzian, T
    Caldwell, LC
    Strong, LC
    El-Naggar, AK
    Lozano, G
    [J]. CELL, 2004, 119 (06) : 861 - 872
  • [9] Modulation of mammalian life span by the short isoform of p53
    Maier, B
    Gluba, W
    Bernier, B
    Turner, T
    Mohammad, K
    Guise, T
    Sutherland, A
    Thorner, M
    Scrable, H
    [J]. GENES & DEVELOPMENT, 2004, 18 (03) : 306 - 319
  • [10] A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
    Marin, MC
    Jost, CA
    Brooks, LA
    Irwin, MS
    O'Nions, J
    Tidy, JA
    James, N
    McGregor, JM
    Harwood, CA
    Yulug, IG
    Vousden, KH
    Allday, MJ
    Gusterson, B
    Ikawa, S
    Hinds, PW
    Crook, T
    Kaelin, WG
    [J]. NATURE GENETICS, 2000, 25 (01) : 47 - 54